Timothy Herpin

Bio:

Tim has over twenty years of business development experience across pharmaceutical and biotech companies. Previously, he was Chief Business Officer at Santa Ana Bio, a precision immunology company developing antibodies and ADCs for autoimmune and inflammatory diseases. During the pandemic, he headed the business development team for infectious diseases and vaccines at Johnson and Johnson. Prior to J&J, Tim was CBO at Caribou Biosciences, a CRISPR gene editing company developing a portfolio of allogeneic cell therapies for oncology. Tim spent seven years with AstraZeneca leading business development teams for the neuroscience and oncology disease areas, as well as leading a transaction team involved with large and complex deals. Tim started his BD career at Bristol-Myers Squibb covering search, evaluation and transaction in multiple disease areas. Before business development, Tim worked as a medicinal chemist at Bristol-Myers Squibb, Aventis and Pharmacopeia.

Tim grew up in Paris and is a graduate of Ecole Polytechnique in France. He also holds a Ph.D. in organic chemistry from University College London and an MBA in Finance from NYU Stern.